
Elizabeth A. Burkhart
Examiner (ID: 12400, Phone: (571)272-6647 , Office: P/1715 )
| Most Active Art Unit | 1715 |
| Art Unit(s) | 1762, 1715, 1792 |
| Total Applications | 919 |
| Issued Applications | 503 |
| Pending Applications | 11 |
| Abandoned Applications | 404 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5590405
[patent_doc_number] => 20060039856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Magnetic resonance with stimulation'
[patent_app_type] => utility
[patent_app_number] => 11/255806
[patent_app_country] => US
[patent_app_date] => 2005-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3645
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20060039856.pdf
[firstpage_image] =>[orig_patent_app_number] => 11255806
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/255806 | Magnetic resonance with stimulation | Oct 20, 2005 | Abandoned |
Array
(
[id] => 5595703
[patent_doc_number] => 20060159619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Cell permeable nanoconjugates of shell-crosslinked knedel (SCK) and peptide nucleic acids (\"PNAs\") with uniquely expressed or over-expressed mRNA targeting sequences for early diagnosis and therapy of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/250830
[patent_app_country] => US
[patent_app_date] => 2005-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 47192
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20060159619.pdf
[firstpage_image] =>[orig_patent_app_number] => 11250830
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/250830 | Cell permeable nanoconjugates of shell-crosslinked knedel (SCK) and peptide nucleic acids (“PNAsâ€) with uniquely expressed or over-expressed mRNA targeting sequences for early diagnosis and therapy of cancer | Oct 13, 2005 | Issued |
Array
(
[id] => 11721245
[patent_doc_number] => 09694092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-04
[patent_title] => 'Stabalised 99mTc compositions'
[patent_app_type] => utility
[patent_app_number] => 11/721064
[patent_app_country] => US
[patent_app_date] => 2005-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7398
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11721064
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/721064 | Stabalised 99mTc compositions | Oct 13, 2005 | Issued |
Array
(
[id] => 11721245
[patent_doc_number] => 09694092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-04
[patent_title] => 'Stabalised 99mTc compositions'
[patent_app_type] => utility
[patent_app_number] => 11/721064
[patent_app_country] => US
[patent_app_date] => 2005-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7398
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11721064
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/721064 | Stabalised 99mTc compositions | Oct 13, 2005 | Issued |
Array
(
[id] => 5636908
[patent_doc_number] => 20060067881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products'
[patent_app_type] => utility
[patent_app_number] => 11/248541
[patent_app_country] => US
[patent_app_date] => 2005-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 42732
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20060067881.pdf
[firstpage_image] =>[orig_patent_app_number] => 11248541
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/248541 | Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products | Oct 11, 2005 | Abandoned |
Array
(
[id] => 5715139
[patent_doc_number] => 20060078502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Charge neutral complexes of paramagnetic metals as intracellular magnetic resonance imaging contrast agents'
[patent_app_type] => utility
[patent_app_number] => 11/242064
[patent_app_country] => US
[patent_app_date] => 2005-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7183
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20060078502.pdf
[firstpage_image] =>[orig_patent_app_number] => 11242064
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/242064 | Charge neutral complexes of paramagnetic metals as intracellular magnetic resonance imaging contrast agents | Oct 3, 2005 | Issued |
Array
(
[id] => 5391095
[patent_doc_number] => 20090208408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'USE OF VCAM-1 LIGANDS FOR DETECTING AND/OR TREATING CARDIOVASCULAR DISEASES'
[patent_app_type] => utility
[patent_app_number] => 11/576480
[patent_app_country] => US
[patent_app_date] => 2005-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8507
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20090208408.pdf
[firstpage_image] =>[orig_patent_app_number] => 11576480
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576480 | USE OF VCAM-1 LIGANDS FOR DETECTING AND/OR TREATING CARDIOVASCULAR DISEASES | Sep 29, 2005 | Abandoned |
Array
(
[id] => 9112521
[patent_doc_number] => 08568689
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-10-29
[patent_title] => 'uPAR-targeting contrast agents'
[patent_app_type] => utility
[patent_app_number] => 11/576193
[patent_app_country] => US
[patent_app_date] => 2005-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7264
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11576193
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576193 | uPAR-targeting contrast agents | Sep 27, 2005 | Issued |
Array
(
[id] => 4839284
[patent_doc_number] => 20080279769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Enzyme Inhibitor Imaging Agents'
[patent_app_type] => utility
[patent_app_number] => 11/575977
[patent_app_country] => US
[patent_app_date] => 2005-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18484
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20080279769.pdf
[firstpage_image] =>[orig_patent_app_number] => 11575977
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/575977 | Enzyme Inhibitor Imaging Agents | Sep 22, 2005 | Abandoned |
Array
(
[id] => 5739079
[patent_doc_number] => 20060009470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Method for specifically potentiating N-type Ca2+ channel activity'
[patent_app_type] => utility
[patent_app_number] => 11/228325
[patent_app_country] => US
[patent_app_date] => 2005-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4413
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009470.pdf
[firstpage_image] =>[orig_patent_app_number] => 11228325
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/228325 | Method for specifically potentiating N-type Ca2+ channel activity | Sep 18, 2005 | Abandoned |
Array
(
[id] => 4791582
[patent_doc_number] => 20080292555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Quantitative Two-Photon Flow Cytometry'
[patent_app_type] => utility
[patent_app_number] => 11/662835
[patent_app_country] => US
[patent_app_date] => 2005-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4733
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20080292555.pdf
[firstpage_image] =>[orig_patent_app_number] => 11662835
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/662835 | Quantitative two-photon flow cytometry | Sep 15, 2005 | Issued |
Array
(
[id] => 4886314
[patent_doc_number] => 20080260646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Imaging Reporters of Transgene Expression'
[patent_app_type] => utility
[patent_app_number] => 11/575057
[patent_app_country] => US
[patent_app_date] => 2005-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 30538
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20080260646.pdf
[firstpage_image] =>[orig_patent_app_number] => 11575057
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/575057 | Imaging reporters of transgene expression | Sep 15, 2005 | Issued |
Array
(
[id] => 5894317
[patent_doc_number] => 20060002856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Methods for in vivo evaluation of physiological conditions and/or organ or system function including methods to evaluate cardiopulmonary disorders such as chronic heart failure using polarized 129Xe'
[patent_app_type] => utility
[patent_app_number] => 11/224204
[patent_app_country] => US
[patent_app_date] => 2005-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13911
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20060002856.pdf
[firstpage_image] =>[orig_patent_app_number] => 11224204
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/224204 | Methods for in vivo evaluation of physiological conditions and/or organ or system function including methods to evaluate cardiopulmonary disorders such as chronic heart failure using polarized 129Xe | Sep 11, 2005 | Abandoned |
Array
(
[id] => 5894316
[patent_doc_number] => 20060002855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Targeted combination immunotherapy of cancer and infectious diseases'
[patent_app_type] => utility
[patent_app_number] => 11/210684
[patent_app_country] => US
[patent_app_date] => 2005-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11777
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20060002855.pdf
[firstpage_image] =>[orig_patent_app_number] => 11210684
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/210684 | Targeted combination immunotherapy of cancer and infectious diseases | Aug 24, 2005 | Issued |
Array
(
[id] => 4898827
[patent_doc_number] => 20080118440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-22
[patent_title] => 'Imaging Cellular Nucleic Acids'
[patent_app_type] => utility
[patent_app_number] => 11/574160
[patent_app_country] => US
[patent_app_date] => 2005-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 12808
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11574160
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/574160 | Imaging Cellular Nucleic Acids | Aug 22, 2005 | Abandoned |
Array
(
[id] => 4999269
[patent_doc_number] => 20070041903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Modified minigastrin analogs for oncology applications'
[patent_app_type] => utility
[patent_app_number] => 11/206757
[patent_app_country] => US
[patent_app_date] => 2005-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5614
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20070041903.pdf
[firstpage_image] =>[orig_patent_app_number] => 11206757
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/206757 | Modified minigastrin analogs for oncology applications | Aug 18, 2005 | Abandoned |
Array
(
[id] => 12930
[patent_doc_number] => 07803351
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-28
[patent_title] => 'Blood brain barrier permeation peptides'
[patent_app_type] => utility
[patent_app_number] => 11/207954
[patent_app_country] => US
[patent_app_date] => 2005-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 17
[patent_no_of_words] => 23615
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/803/07803351.pdf
[firstpage_image] =>[orig_patent_app_number] => 11207954
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/207954 | Blood brain barrier permeation peptides | Aug 18, 2005 | Issued |
Array
(
[id] => 82233
[patent_doc_number] => 07745590
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-06-29
[patent_title] => 'Degradable macromolecular magnetic resonance imaging contrast agents and methods thereof'
[patent_app_type] => utility
[patent_app_number] => 11/203799
[patent_app_country] => US
[patent_app_date] => 2005-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4338
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/745/07745590.pdf
[firstpage_image] =>[orig_patent_app_number] => 11203799
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/203799 | Degradable macromolecular magnetic resonance imaging contrast agents and methods thereof | Aug 14, 2005 | Issued |
Array
(
[id] => 800176
[patent_doc_number] => 07425318
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-16
[patent_title] => 'Amyloid plaque aggregation inhibitors and diagnostic imaging agents'
[patent_app_type] => utility
[patent_app_number] => 11/203429
[patent_app_country] => US
[patent_app_date] => 2005-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11452
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/425/07425318.pdf
[firstpage_image] =>[orig_patent_app_number] => 11203429
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/203429 | Amyloid plaque aggregation inhibitors and diagnostic imaging agents | Aug 14, 2005 | Issued |
Array
(
[id] => 32453
[patent_doc_number] => 07785565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-31
[patent_title] => 'Metal chelators and methods of their use'
[patent_app_type] => utility
[patent_app_number] => 11/659601
[patent_app_country] => US
[patent_app_date] => 2005-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7694
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/785/07785565.pdf
[firstpage_image] =>[orig_patent_app_number] => 11659601
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/659601 | Metal chelators and methods of their use | Aug 8, 2005 | Issued |